top of page
Starting August 1, 2024, Quickarrays Inc. will be taking over Pantomics Inc. to
provide all products and services. Please visit Quickarrays Inc. for more information.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
Hermatopathology
EMC481
Endometrial cancer tissue array, 16 cases, 48 cores, one normal endometrial tissue corepaired with two tumor tissue cores from each patient, with grading and TNM staging data.
Price per slide:
$289
Species:
Human
Cases:
16
Cores:
48
Core Size:
1.5mm
Core Thickness:
4um
Rows:
6
Columns:
8
Format:
Intended Usage:
For research use only. Designed for normal vs cancer IHC or ISH based protein or RNA tissue profiling in endometrium cancers.
6
X
8
For illustration purpose only. Actual product may vary.
Notes:
All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.
Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | NATURE | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|---|
A01 |  | F | 42 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
A02 |  | F | 45 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
A03 |  | F | 48 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T3N0M0 |
A04 |  | F | 41 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
A05 |  | F | 38 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T2N0M0 |
A06 |  | F | 57 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
A07 |  | F | 50 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
A08 |  | F | 50 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T3N0M0 |
B01 |  | F | 42 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
B02 |  | F | 45 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
B03 |  | F | 48 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T3N0M0 |
B04 |  | F | 41 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
B05 |  | F | 38 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T2N0M0 |
B06 |  | F | 57 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
B07 |  | F | 50 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
B08 |  | F | 50 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T3N0M0 |
C01 |  | F | 42 | Uterus, endometrium | Uninvolved endometrium tissue of A1,B1 | Normal | ||
C02 |  | F | 45 | Uterus, endometrium | Uninvolved endometrium tissue of A2,B2 | Normal | ||
C03 |  | F | 48 | Uterus, endometrium | Uninvolved endometrium tissue of A3,B3 | Normal | ||
C04 |  | F | 41 | Uterus, endometrium | Uninvolved endometrium tissue of A4,B4 | Normal | ||
C05 |  | F | 38 | Uterus, endometrium | Uninvolved endometrium tissue of A5,B5 | Normal | ||
C06 |  | F | 57 | Uterus, endometrium | Uninvolved endometrium tissue of A6,B6 | Normal | ||
C07 |  | F | 50 | Uterus, endometrium | Uninvolved endometrium tissue of A7,B7 | Normal | ||
C08 |  | F | 50 | Uterus, endometrium | Uninvolved endometrium tissue of A8,B8 | Normal | ||
D01 |  | F | 43 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
D02 |  | F | 44 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T2N0M0 |
D03 |  | F | 57 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N1M0 |
D04 |  | F | 58 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
D05 |  | F | 40 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T1N0M0 |
D06 |  | F | 56 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
D07 |  | F | 52 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T3N1M0 |
D08 |  | F | 41 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
E01 |  | F | 43 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
E02 |  | F | 44 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T2N0M0 |
E03 |  | F | 57 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N1M0 |
E04 |  | F | 58 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
E05 |  | F | 40 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T1N0M0 |
E06 |  | F | 56 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
E07 |  | F | 52 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T3N1M0 |
E08 |  | F | 41 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
F01 |  | F | 43 | Uterus, endometrium | Uninvolved endometrium tissue of A1,B1 | Normal | ||
F02 |  | F | 44 | Uterus, endometrium | Uninvolved endometrium tissue of A2,B2 | Normal | ||
F03 |  | F | 57 | Uterus, endometrium | Uninvolved endometrium tissue of A3,B3 | Normal | ||
F04 |  | F | 58 | Uterus, endometrium | Uninvolved endometrium tissue of A4,B4 | Normal | ||
F05 |  | F | 40 | Uterus, endometrium | Uninvolved endometrium tissue of A5,B5 | Normal | ||
F06 |  | F | 56 | Uterus, endometrium | Uninvolved endometrium tissue of A6,B6 | Normal | ||
F07 |  | F | 52 | Uterus, endometrium | Uninvolved endometrium tissue of A7,B7 | Normal | ||
F08 |  | F | 41 | Uterus, endometrium | Uninvolved endometrium tissue of A8,B8 | Normal |
bottom of page